Review: could Tysabri cause Progressive multifocal leukoencephalopathy?
Summary: Progressive multifocal leukoencephalopathy is found among people who take Tysabri, especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years, also take medication Baclofen, and have Multiple sclerosis.
We study 97,549 people who have side effects while taking Tysabri from FDA and social media. Among them, 2,943 have Progressive multifocal leukoencephalopathy. Find out below who they are, when they have Progressive multifocal leukoencephalopathy and more.
You are not alone: join a support group for people who take Tysabri and have Progressive multifocal leukoencephalopathy >>>
Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. (latest outcomes from 97,689 Tysabri users)
Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells) has been reported by people with multiple sclerosis, relapsing-remitting multiple sclerosis, chronic lymphocytic leukaemia, rheumatoid arthritis, non-hodgkin's lymphoma. (latest reports from 5,167 Progressive multifocal leukoencephalopathy patients)
On Mar, 27, 2015: 97,547 people reported to have side effects when taking Tysabri. Among them, 2,943 people (3.02%) have Progressive Multifocal Leukoencephalopathy.
Time on Tysabri when people have Progressive multifocal leukoencephalopathy * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Progressive multifocal leukoencephalopathy||2.76%||3.48%||4.88%||15.32%||68.96%||4.56%||0.04% |
Gender of people who have Progressive multifocal leukoencephalopathy when taking Tysabri * :
|Progressive multifocal leukoencephalopathy||68.23%||31.77% |
Age of people who have Progressive multifocal leukoencephalopathy when taking Tysabri * :
|Progressive multifocal leukoencephalopathy||0.00%||0.00%||0.74%||6.41%||23.34%||37.93%||21.97%||9.62% |
Severity of Progressive multifocal leukoencephalopathy when taking Tysabri ** :
|least||moderate||severe||most severe |
|Progressive multifocal leukoencephalopathy||0.00%||0.00%||0.00%||100.00% |
How people recovered from Progressive multifocal leukoencephalopathy ** :
Top conditions involved for these people * :
- Multiple sclerosis (2,186 people, 74.28%)
- Relapsing-remitting multiple sclerosis (638 people, 21.68%)
- Depression (180 people, 6.12%)
- Muscle spasticity (146 people, 4.96%)
- Fatigue (99 people, 3.36%)
Top co-used drugs for these people * :
- Baclofen (213 people, 7.24%)
- Vitamin d (146 people, 4.96%)
- Lyrica (108 people, 3.67%)
- Provigil (103 people, 3.50%)
- Zanaflex (100 people, 3.40%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of tysabri and progressive multifocal leukoencephalopathy on
Do you have Progressive Multifocal Leukoencephalopathy while taking Tysabri?
You are not alone! Join a support group on :
- support group for people who take Tysabri and have Progressive Multifocal Leukoencephalopathy
- support group for people who take Tysabri
- support group for people who have Progressive Multifocal Leukoencephalopathy
Drugs in real world that are associated with:
Could your condition cause:
Recent Tysabri related drug comparison:
- Comparions of Tysabri, Tecfidera, Gilenya, Avonex for a 36-year old woman who has RRMS
- Comparions of Vesicare, Ampyra, Zocor, Tysabri, Baclofen for a 45-year old woman who has Multiple Sclerosis Relapse
- Comparions of Tysabri, Gilenya for a 48-year old man who has Multiple Sclerosis
- Comparions of Tysabri, Copaxone for a 44-year old woman who has MS
- Comparions of Lyrica, Tysabri for a 27-year old woman who has Multiple Sclerosis
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.